Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 11
Corrigendum
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,902 | Dovepress* | 8,682+ | 1,532 | 10,214 | |
| PubMed Central* | 220 | 80 | 300 | ||
| Totals | 8,902 | 1,612 | 10,514 | ||
| *Since 14 January 2019 | |||||
View citations on PubMed Central and Google Scholar